3UE-32457-06813 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-08
Dose 1 — Pfizer-BioNTech
2021-03-11
Dose 2 — Pfizer-BioNTech
2021-03-26
Registered in v-safe
2021-03-26
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2022-03-11
Survey response — 12 months, dose 2
MedDRA: Blister, Cough, Haemorrhage, Headache, Rash — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Cough, blood, blisters, rash, headache.

MedDRA releases: 2024-11 · check-in free text available
2022-03-11
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-03-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-08	Pfizer-BioNTech
2	2021-03-11	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-03-11	Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-03-11

Symptoms: Cough, blood, blisters, rash, headache.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Blister	·	·	✓
SD	Cough	·	·	✓
SD	Haemorrhage	·	·	✓
SD	Headache	·	·	✓
SD	Rash	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release